The benefit of H2 receptors antagonist Rupatadine in treatment for urticaria
Second generation antihistamine drugs are mainly used for the therapy of patients suffering from urticaria; however, they are efficient in 45-60% of cases only. New drugs for treatment of urticaria need to be developed and implemented, and second generation antihistamine drug Rupatadine is one of th...
Saved in:
Main Authors: | A. A. Kubanov (Author), V. V. Chikin (Author) |
---|---|
Format: | Book |
Published: |
State Scientific Center of Dermatovenereology and Cosmetology,
2017-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
How to handle off-label prescriptions of rupatadine, a second-generation antihistamine and PAF antagonist: a review
by: Iñaki Izquierdo, et al.
Published: (2024) -
Role of Leukotriene receptor antagonist Montelukast in the treatment of chronic urticaria: A hospital based study
by: Iffat Hassan, et al.
Published: (2012) -
Application of capillary zone electrophoresis to determine second-generation H1 antihistaminic drugs, loratadine and rupatadine
by: Cintia Maria Alves Mothé, et al.
Published: (2023) -
Effects of H2-Receptor Antagonists on the Exposure of Dacomitinib
by: Jian Liu, et al.
Published: (2024) -
Comparison of efficacy, safety and cost-effectiveness of rupatadine and olopatadine in patients of chronic spontaneous urticaria: A randomized, double-blind, comparative, parallel group trial
by: Ganesh N Dakhale, et al.
Published: (2016)